Resources
The National Pharmaceutical Council (NPC) is a health policy research organization dedicated to the advancement of good evidence and science, and to fostering an environment in the United States that supports medical innovation.
Filter by:
Topic
Topic
- Accountable Care Organizations
- Alternative Payment Models
- Biopharmaceutical Innovation
- Bundled Payments
- Clinical Pathways
- Decision Frameworks
- Elements of Value
- Evidence for Decision Making
- Formulary/Benefit Design
- Formulary Development
- Good Practices for Evidence
- Health Care Quality Measures
- Health Spending
- Health Spend Management
- High-Deductible Health Plans
- Impact on Outcome & Spending
- Individual Treatment Effects & Personalized Access
- Low-Value Care
- Pandemic Response
- Patient Cost Sharing
- Paying for Cures
- Policy & Regulatory Barriers
- Real-World Data
- Real-World Evidence
- Regulatory Barriers & Challenges
- Understanding Health Spending
- Utilization Management & Step Therapy
- Value-Based Contracts
- Value-Based Insurance Design
- Value Assessment
- Value Assessment Frameworks
- Value Assessment Methods
Resource Type
Audience
Audience
Display Only
Showing 587 Results
NPC @ HIX Summit: How Rx and Pharma Will Participate in the Exchanges
One of the most pressing issues in the implementation of the Affordable Care Act (ACA) is whether the state health insurance exchanges, or marketplaces, will be effective in achieving their primary…
Coming Attraction: You Get What You Pay For: Will ACOs Underuse Drugs?
Exactly one month from today, the National Pharmaceutical Council will host a pre-conference educational symposium on one of the most buzzed-about topics in health care—accountable care organizations…
NPC Webinar to Examine the State of Comparative Effectiveness Research & Health Care Decision-Making
Which organizations are considered key players in funding, monitoring, and developing standards for comparative effectiveness research (CER)? Do health care stakeholders think that CER is already…
#TBT: Making Informed Decisions: What Kinds of Studies Will PCORnet Undertake?
As part of our “Throwback Thursday” blog series, we’re taking a look at a topic that’s currently in the news and tagging it with previous research, videos or commentaries in a relevant way…
#TBT: Medicaid Expansion & Historical Data
As part of our “Throwback Thursday” blog series, we’re taking a look at a topic that’s currently in the news and tagging it with previous research, videos or commentaries in a relevant way…
4/8 Webinar on CER Collaborative: Tools You Can Use
The CER Collaborative--a group formed by the Academy of Managed Care Pharmacy (AMCP), the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and the National Pharmaceutical…
#TBT: Enrollment Deadline & the Role of Rx in Health Exchanges
As part of our “Throwback Thursday” blog series, we’re taking a look at a research topic that’s currently in the news and tagging it with previous research, videos or commentaries in a…
CER Collaborative Rolls Out New Resources to Aid Formulary Decision-Making
A newly published series of peer-reviewed articles developed by the CER Collaborative will help formulary decision-makers more effectively evaluate comparative effectiveness research (CER) studies…
The New Pharmaceutical Paradigm: Capturing Value, Improving Access, and Maximizing Outcomes
Dr. Chuck Shih, NPC’s fellow in comparative effectiveness research, discusses how the use and management of pharmaceuticals are being integrated into new care delivery and payment models in a column…
Practice-Based Research Networks: Will Their Promise Become Reality?
Practice-based research networks (PBRNs) could provide “real-world” answers to health care treatment questions, but researchers must first address a variety of evidence, regulatory and communications…
#TBT: Alzheimer’s & Access to Health Information
As part of our “Throwback Thursday” blog series, we’re taking a look at a research topic that’s currently in the news and tagging it with previous research, videos or commentaries in a…
NPC Asks CMS to Consider Patients’ Individual Treatment Effects In Part D Rulemaking
The National Pharmaceutical Council (NPC) today asked the Centers for Medicare and Medicaid Services (CMS) to consider maintaining “protected classes” designations under its prescription drug benefit…
ICYMI: Articles of Interest (February 2014)
It’s nearly impossible to stay on top of all the articles you need to read when thousands of peer-reviewed journal articles are published each month. Below are a handful of articles concerning…
#TBT: Need Evidence to Inform Health Decisions? Do it GRACEfully with our Checklist
As part of our “Throwback Thursday” blog series, we’re taking a look at a research topic that’s currently in the news and tagging it with previous research, videos or commentaries in a…
#TBT: Bob Costas, Presenteeism and Its Impact on Productivity
As part of our “Throwback Thursday” blog series, we’re taking a look at a research topic that’s currently in the news and tagging it with previous research, videos or commentaries in a relevant way…
ICYMI: CER Articles of Interest
With thousands of peer-reviewed journal articles published each month, it’s nearly impossible to stay on top of all the articles you need to read. That’s why we’ve highlighted a handful of articles…
How Can Big Data Improve Innovation and Health Care?
The use of “big data” is growing rapidly in health-related research, but how can it be leveraged to improve innovation and health care?Join experts from the Food and Drug Administration (FDA),…
ACOs and Medication Management
Recent research has shown that many accountable care organizations (ACOs) have room for improvement, with a key finding being the potential value of expanding the role of pharmacists in the ACO…
#TBT: Pragmatic Clinical Trials
After deciding that we didn’t want to post embarrassing photos on Instagram, we opted instead to bring the “Throwback Thursday” concept to our blog. Starting today, on every other Thursday we’re…
PCORI to Study More Head-to-Head Comparisons in 2014
At a conference last week, Patient-Centered Outcomes Research Institute (PCORI) Executive Director Dr. Joe Selby announced plans to fund more comparative effectiveness research (CER) examining head…